Adam Johnson
Cardiovascular Disease Fellow · Past training
Recent Alumni · Massachusetts General Hospital
Training
Cardiovascular Disease Fellowship at Massachusetts General Hospital (previously observed).
Education includes Johns Hopkins University and Weill Cornell Medicine.
Explore education and trainingResearch
71 attributed works, including 30 as first author. Explore the publications and documented research affiliations.
Explore researchEducation and training
Johns Hopkins University · Weill Cornell Medicine
Residency · Massachusetts General Hospital
Research
Publications
71 attributed works · 30 first author. Counts reflect resolved authorship and may be incomplete.
- 2026Personalized artificial intelligence based left ventricular ejection fraction and systolic dysfunction assessmentnpj Digital Medicine0 citesPMID 41951962
- 2026The emerging role of CETP inhibition in the prevention of Alzheimer's diseaseAmerican Journal of Preventive Cardiology0 citesPMID 42006409
- 2025Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosisJournal of Antimicrobial ChemotherapyRCR 2.637 citesPMID 40990169
- 2025Resident-Driven Guideline to Reduce Iatrogenic Pneumothoraxes From Small-Bore Feeding Tubes: A Quality and Safety Improvement ProjectAmerican Journal of Medical Qualitysenior author0 citesPMID 39789743
- 2024
- 2023Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activityBioorganic & Medicinal Chemistry LettersRCR 0.402 citesPMID 37146837
- 2023TRANSCRIPTOMIC ANALYSIS OF TISSUE BIOPSIES FROM CALCIPHYLAXIS PATIENTS REVEALS NOVEL DIFFERENTIALLY EXPRESSED GENES RELATED TO CALCIFICATION, THROMBOSIS, AND INFLAMMATIONJournal of the American College of Cardiology
- 2023P369: SATB2-associated syndrome severity score: Genotype/phenotype correlations and the SATB2 portalGenetics in Medicine Open
- 2022Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceJournal of Antimicrobial ChemotherapyRCR 2.0518 citesPMID 35170719
- 2022Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trialStem Cell Research & TherapyRCR 1.0210 citesPMID 35715872
- 2022Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonanceBioMetalsRCR 0.081 citesPMID 35639270
- 2020Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>Antimicrobial Agents and Chemotherapyfirst authorRCR 2.4336 citesPMID 32253209
- 2020Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>Antimicrobial Agents and ChemotherapyRCR 1.1017 citesPMID 32778549
- 2020LibGuides: HUM 1020 (Hoaglen) - Introduction to Humanities : Late Romanfirst author
- 2020LibGuides: HUM 1020 (Disser) - Introduction to Humanities: Homefirst author
- 2020TPL2 kinase action and control of inflammationThe Journal of Immunology
Sources
Roster sources establish the listed training role. Additional education, career, and research sources are added as the profile is enriched.
Program context: Cardiovascular Disease Fellowship